January 25, 2026 a 09:31 am
Healthcare Stocks - Performance Analysis
The healthcare sector has witnessed substantial fluctuation over recent periods, specifically driven by various macroeconomic factors and changing market sentiments. This analysis reviews performance over three critical periods: one week, one month, and three months. It aims to deliver insights into the key drivers behind these changes and helps strategize future investments.
Healthcare Stocks Performance One Week 📊
During the past week, the healthcare sector faced volatility, marked by a pronounced upward swing from certain stocks while others faced downturns. Notably, the stock of UnitedHealth Group (UNH) exhibited strong performance, while Abbott Laboratories (ABT), faced significant declines.
| Stock | Performance (%) | Performance |
|---|---|---|
| UNH | 7.42 | |
| AMGN | 4.33 | |
| LLY | 2.56 | |
| ABBV | 2.31 | |
| TMO | 1.23 | |
| JNJ | 0.68 | |
| MRK | -0.57 | |
| ISRG | -2.07 | |
| ABT | -11.99 |
Healthcare Stocks Performance One Month 📈
Within the one-month timeframe, Thermo Fisher Scientific Inc. (TMO) showed robust growth, contrasting sharply with underperformance seen in Abbott Laboratories (ABT). The overall month showed a mixed bag of performance with several stocks demonstrating resilience amid market pressure.
| Stock | Performance (%) | Performance |
|---|---|---|
| TMO | 7.72 | |
| UNH | 7.34 | |
| JNJ | 5.96 | |
| AMGN | 3.79 | |
| MRK | 1.44 | |
| LLY | -0.85 | |
| ABBV | -4.41 | |
| ISRG | -9.54 | |
| ABT | -14.44 |
Healthcare Stocks Performance Three Months 📉
The three-month analysis showcases Eli Lilly and Company (LLY) as a remarkable top performer with a significant upside. Conversely, Abbott Laboratories (ABT) continues to be the most notable underperformer in this longer timeframe.
| Stock | Performance (%) | Performance |
|---|---|---|
| LLY | 26.46 | |
| MRK | 21.56 | |
| AMGN | 17.93 | |
| TMO | 10.93 | |
| JNJ | 14.95 | |
| UNH | -1.76 | |
| ABBV | -3.01 | |
| ISRG | -4.41 | |
| ABT | -16.00 |
Summary 💡
In conclusion, while certain healthcare stocks like Eli Lilly & Company and UnitedHealth Group exhibit promising performance, others such as Abbott Laboratories require caution and scrutiny, particularly over extended periods. Investors should balance their portfolios carefully, considering current market volatility and sector-specific influences. A diversified approach remains advisable to mitigate potential downsides.